2.5 mg tirzepatide on syringe Dosage Chart & Dosing Guide for Weight Loss Mounjaro (Tirzepatide) Injection 7.5 mg/0.5

Tirzepatide is the first drug that uses the action of two hormones, GLP-1 and GIP, for greater effects

Lancet 375 , 481489 (2010)

Developed by Innovent Biologics (under license from Eli Lilly), Mazdutide is already approved in China for both chronic weight management and type 2 diabetesthe first dual GCG/GLP-1 therapy with regulatory clearance

Those modifications are why semaglutide works as a once-weekly injection rather than requiring multiple daily doses

Glutathione is a potent antioxidant that plays many roles in disease prevention and treatment

We offer a limited selection of our peptides without a providers oversight